303 related articles for article (PubMed ID: 22027547)
1. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial.
Gillgren P; Drzewiecki KT; Niin M; Gullestad HP; Hellborg H; Månsson-Brahme E; Ingvar C; Ringborg U
Lancet; 2011 Nov; 378(9803):1635-42. PubMed ID: 22027547
[TBL] [Abstract][Full Text] [Related]
2. Excision margins in high-risk malignant melanoma.
Thomas JM; Newton-Bishop J; A'Hern R; Coombes G; Timmons M; Evans J; Cook M; Theaker J; Fallowfield M; O'Neill T; Ruka W; Bliss JM; ; ;
N Engl J Med; 2004 Feb; 350(8):757-66. PubMed ID: 14973217
[TBL] [Abstract][Full Text] [Related]
3. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
4. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.
Cohn-Cedermark G; Rutqvist LE; Andersson R; Breivald M; Ingvar C; Johansson H; Jönsson PE; Krysander L; Lindholm C; Ringborg U
Cancer; 2000 Oct; 89(7):1495-501. PubMed ID: 11013363
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm.
Hunger RE; Angermeier S; Seyed Jafari SM; Ochsenbein A; Shafighi M
J Am Acad Dermatol; 2015 Jun; 72(6):1054-9. PubMed ID: 25877659
[TBL] [Abstract][Full Text] [Related]
6. One-cm Versus 2-cm Excision Margins for Patients With Intermediate Thickness Melanoma: A Matched-Pair Analysis.
Koskivuo I; Giordano S; Veräjänkorva E; Vihinen P
Dermatol Surg; 2015 Oct; 41(10):1130-6. PubMed ID: 26356846
[TBL] [Abstract][Full Text] [Related]
7. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.
Ringborg U; Andersson R; Eldh J; Glaumann B; Hafström L; Jacobsson S; Jönsson PE; Johansson H; Krysander L; Lagerlöf B
Cancer; 1996 May; 77(9):1809-14. PubMed ID: 8646678
[TBL] [Abstract][Full Text] [Related]
8. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick).
Khayat D; Rixe O; Martin G; Soubrane C; Banzet M; Bazex JA; Lauret P; Vérola O; Auclerc G; Harper P; Banzet P;
Cancer; 2003 Apr; 97(8):1941-6. PubMed ID: 12673721
[TBL] [Abstract][Full Text] [Related]
9. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.
Haigh PI; DiFronzo LA; McCready DR
Can J Surg; 2003 Dec; 46(6):419-26. PubMed ID: 14680348
[TBL] [Abstract][Full Text] [Related]
10. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
Veronesi U; Cascinelli N; Adamus J; Balch C; Bandiera D; Barchuk A; Bufalino R; Craig P; De Marsillac J; Durand JC
N Engl J Med; 1988 May; 318(18):1159-62. PubMed ID: 3079582
[TBL] [Abstract][Full Text] [Related]
11. Surgical excision margins for primary cutaneous melanoma.
Sladden MJ; Balch C; Barzilai DA; Berg D; Freiman A; Handiside T; Hollis S; Lens MB; Thompson JF
Cochrane Database Syst Rev; 2009 Oct; (4):CD004835. PubMed ID: 19821334
[TBL] [Abstract][Full Text] [Related]
12. The prognosis and treatment of true local cutaneous recurrent malignant melanoma.
Brown CD; Zitelli JA
Dermatol Surg; 1995 Apr; 21(4):285-90. PubMed ID: 7728476
[TBL] [Abstract][Full Text] [Related]
13. Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.
Haydu LE; Stollman JT; Scolyer RA; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Bonenkamp JJ; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1071-81. PubMed ID: 25956574
[TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
15. Excision of fascia in melanoma thicker than 2 mm: no evidence for improved clinical outcome.
Hunger RE; Seyed Jafari SM; Angermeier S; Shafighi M
Br J Dermatol; 2014 Dec; 171(6):1391-6. PubMed ID: 25392906
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.
van der Pas MH; Haglind E; Cuesta MA; Fürst A; Lacy AM; Hop WC; Bonjer HJ;
Lancet Oncol; 2013 Mar; 14(3):210-8. PubMed ID: 23395398
[TBL] [Abstract][Full Text] [Related]
17. Wide excision without radiation for desmoplastic melanoma.
Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
[TBL] [Abstract][Full Text] [Related]
19. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
[TBL] [Abstract][Full Text] [Related]
20. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
